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Available online 20 September 2016We have previously shown that there is a complex and dynamic biological interaction between acute mental
stress and acute release of inflammatory factors into the blood stream in relation to heart disease. We now hy-
pothesize that the presence of chronic psychosocial stressmaymodify theweight of single test results for inflam-
mation as a predictor of heart disease. Using a cross-sectional design, 500 participants free from heart disease
drawn from theWhitehall II study inUK in 2006–2008were tested for plasma fibrinogen as an inflammatory fac-
tor, financial strain as a marker of chronic psychosocial stress, coronary calcification measured using computed
tomography, and for plasma high-sensitivity cardiac troponin T (HS-CTnT) as amarker of cardiac risk. Fibrinogen
concentration levels above the average were associated with a 5-fold increase in the odds of HS-CTnT positivity
only among individuals with financial strain (N=208, OR=4.73, 95%CI= 1.67 to 13.40, P= 0.003). Fibrinogen
was in fact not associatedwith HS-CTnT positivity in peoplewithoutfinancial strain despite the larger size of that
subsample (n= 292, OR= 0.84, 95%CI = 0.42 to 1.67, P= 0.622). A test for interaction on the full sample (N=
500) showed a P value of 0.010 after adjusting for a range of demographics, health behaviours, traditional cardio-
vascular risk factors, psychosocial stressors, inflammatory cytokines, and coronary calcification. In conclusion, el-
evated fibrinogen seems to be cardio-toxic only when is combined with financial strain. Chronic psychosocial
stress may modify the meaning that we should give to single test results for inflammation. Further research is
needed to confirm our results.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Troponin T1. Introduction
Inflammation is recognised as a fundamental determinant of athero-
sclerosis and cardiovascular disease (CVD), which are now indeed la-
belled as inflammatory conditions (Epstein and Ross, 1999; Libby and
Theroux, 2005; Libby, 2013).
Chronic psychosocial stressors such as anxiety and depression are
associated with inflammation (Dimsdale, 2008; Lazzarino et al., 2013a,
2013b, 2013c; Steptoe and Vögele, 1991) and with heart disease with
an effect size that is comparable to that of the traditional risk factors
such as high blood pressure, cholesterol, smoking, etc. (Brotman et al.,
2007; Dimsdale, 2008; Steptoe and Kivimäki, 2012; Kivimäki et al.,
2012).of Hygiene & Tropical Medicine,
zzarino).
. This is an open access article underAlthough the mechanisms involved in these complex pathways of
causation have yet to be clarified genetically and phenotypically, there
have been attempts to add markers of stress and inflammation when
performing cardiovascular risk assessments (Macleod et al., 2007;
Schnohr et al., 2015; Fiscella et al., 2009; Pearson et al., 2003;
Ioannidis and Tzoulaki, 2012). As yet, the novel biomarkers failed to
add substantial predictive accuracy to the equations based on the tradi-
tional risk factors for cardiovascular disease (Boon et al., 2014;
Emerging Risk Factors Collaboration et al., 2012; Goff et al., 2014). It
has been argued that the linear,monophasic approaches used to explain
these mechanisms are not appropriate, and that “until a paradigm shift
is adopted, cardiovascular biomarker research may remain fascinating
but probably unhelpful to medical practice and public health”
(Ioannidis and Tzoulaki, 2012).
In clinical and research settings, chronic systemic inflammation is
flagged using single blood tests for inflammatory biomarkers such as fi-
brinogen, C-reactive protein, and others. We hypothesize that singlethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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models because the results from those tests may vary due to an
individual's exposure to psychosocial stress (either an unhealthy chron-
ic exposure or a healthy acute exposure). In fact, in a laboratory-based
experiment we found that the plasma concentration of inflammatory
biomarkers can change very rapidly (b1 min) after one brief episode
of mild mental stress (Lazzarino et al., 2015). The kind of artificial stress
that we have induced to our study participants was similar to the fre-
quent, mild, stressful events of everyday life. It is therefore arguable
that the concentration of inflammatory biomarkers in the blood has a
physiological continuous oscillation during anyone's everyday life.
Such instability affects the appropriateness of using single blood tests
to flag chronic systemic inflammation. Furthermore, we found a coun-
terintuitive association between baseline inflammation and the extent
of inflammatory reaction to acute stress: people with low baseline in-
flammation had sharp and high inflammatory responses to acute stress,
and this phenotype was associated with low cardiac risk. Conversely,
people with higher baseline inflammation had blunted and lower in-
flammatory responses and presented higher cardiac risk (Lazzarino et
al., 2015). Therefore, a finding of elevated inflammationmight be an in-
dicator of chronic elevation due to chronic psychosocial stress but also
an indicator of a healthy acute response to a recent acute stressful
event. In other words, a finding of elevated inflammationwould be clin-
ically unfavourable only if it is coupled with chronic psychosocial stress,
and favourable if it is due to a healthy stress response in an individual
with good psychosocial adaptation. These dynamics make single tests
for inflammation further difficult to interpret when not impossible.
There are many inter-connected indicators of chronic psychosocial
stress used in the medical literature (Steptoe, 2007). Factors such as fi-
nancial strain, job strain, and social network, can be measured objec-
tively and represent someone's objective exposure to stress. On the
other hand, factors such as depression and anxiety, although have
more clinical meaning, are subjective mental representations. Never-
theless, there is evidence that low socioeconomic status is associated
with depression and anxiety (Lazzarino et al., 2013a, 2013b) and thus
the option of using financial strain as a marker of chronic psychosocial
stress has the advantage of being both an objective measure and that
of being highly correlated with more clinical conditions such as anxiety
and depression. We have preferred financial strain over employment
grade because the latter may not necessarily imply psychosocial stress.
Fibrinogen is a plasma protein produced by the liver and is a major
coagulation factor. It is a positive acute-phase reactant protein (i.e. its
concentration increases with inflammation), it is traditionally consid-
ered as a risk factor for cardiac disease because it promotes formation
of thrombus, and it is considered as an inflammatory cytokine (Lowe
et al., 2004; Stulnig, 2013).
Cardiac Troponin T is amarker ofmyocardial cell damage that is rou-
tinely measured in the peripheral blood plasma for the diagnosis of
acute myocardial infarction in clinical settings. A high-sensitivity assay
(HS-CTnT) has recently been developed and in healthy people it is asso-
ciated with greater incidence of heart disease, cardiovascular mortality,
and all-cause mortality, and is therefore considered the most proximal
sentinel marker of heart disease (de Lemos et al., 2010; deFilippi et al.,
2010).
For those reasons the aim of this study was to determine if financial
strain (marker of chronic psychosocial stress) modifies the association
between single test results for fibrinogen (marker of inflammation)
and positivity for plasma HS-CTnT (marker of cardiac risk), so that
high financial strain would increase the effect size of that association.
2. Methods
2.1. Study design
This cross-sectional study involved participants drawn from the
Whitehall II epidemiological cohort (Marmot et al., 1991) between2006 and 2008 in the United Kingdom (Hamer et al., 2010). The criteria
for entry into the study included no history or objective signs of clinical
or subclinical cardiovascular disease, noprevious diagnosis or treatment
of hypertension, inflammatory diseases, allergies, or kidney disease.
Cardiovascular disease was defined as prior myocardial infarction, sta-
ble or unstable angina, revascularization procedure, heart failure, tran-
sient ischaemic attack, stroke, or electrocardiographic abnormalities
(resting 12-lead electrocardiograms were taken). Volunteers were of
white European origin, aged 53–76 years, and 56.5% were in full-time
employment. Selection was stratified by grade of employment (current
or most recent) to include both higher and lower socioeconomic status
participants. From the initially invited participants (n = 1169), 27.6%
were not eligible (mainly due to use of prescribed medications) and
25.9% declined to take part. There was no evidence of selection bias
due to those exclusions with respect to the known characteristics of
the sample (demographics, health behaviours, and traditional cardio-
vascular risk factors). Participants were prohibited from using any
anti-histamine or anti-inflammatory medication 7 days prior to testing
and were rescheduled if they reported colds or other infections on the
day of testing. Participants gave full informed consent to participate in
the study and ethical approvalwas obtained from theUniversity College
London Hospital committee on the Ethics of Human Research.
2.2. Data collection
We carried out clinical examinations in a light- and temperature-
controlled laboratory. Participants were instructed to refrain from
drinking caffeinated beverages or smoking for at least 2 h before the
study and not to have performed vigorous physical activity or con-
sumed alcohol since the previous evening. Venipuncture was per-
formed using a butterfly needle. Blood pressure was taken 30 min
after needle insertion (using an automated UA-779 digital monitor),
as well as saliva and fasting blood samples.
Financial strain was assessed with an adaptation of the economic
strain measure of Pearlin et al. (1981). This assesses difficulty paying
one's bills, being able to replace items such as furniture or a car when
needed, and being able to provide for one's family in terms of food,
clothing, and medical care. Eight items were presented, with response
options ranging from 1 = no difficulty to 3 = very great difficulty
(Cronbach's alpha = 0.86). Therefore possible values range from 8
(lowest financial strain) to 24 (highest financial strain) (Steptoe et al.,
2005). Other psychosocial stressorswere assessed, includingdepression
symptoms as measured using the Centre for Epidemiologic Studies De-
pression Scale (CES-D) (Eaton et al., 2004), and mental quality of life as
measured using the 36-item Short Form Health Survey (SF-36) (Ware
and Sherbourne, 1992). We derived two scores from the SF-36: mental
health (items 9b–d and 9f–h) andmental component (items 5, 6, 9, and
10). We also used the PANAS scale to measure positive and negative af-
fect (Watson et al., 1988).
We determined plasma fibrinogen concentration by an automated
Clauss assay in aMDA-180 coagulometer (Organon Teknika, Cambridge,
UK) using the manufacturer's reagents and the International fibrinogen
standard (Gaffney and Wong, 1992).
Wemeasured cardiac troponin T plasma concentration using a high-
ly sensitive assay on an automated platform (Elecsys 2010 Troponin T
hs STAT, Roche Diagnostics) (Collinson, 2011; Giannitsis et al., 2010).
We assessed coronary artery calcification (CAC Agatston score) in
separate sessions using electron beam computed tomography (GE
Imatron C-150, San Francisco, CA, USA) as previously described
(Anand et al., 2007).
2.3. Data analysis
We recoded fibrinogen as a Z-score or as a binary variable. We set
two different cut-off points for the binary categorisation so that we
could evaluate whether the interaction between fibrinogen and
Table 1
Characteristics of the study sample by categories of financial strain for 500 disease-free
participants drawn from the Whitehall II epidemiological cohort between 2006 and
2008 in United Kingdom.
Factor and category Financial strain P
No Yes
(n = 292) (n = 208)
Fibrinogen (mean mg/dL ± SD) 307.4 ±
56.5
322.1 ±
65.3
0.008
Age (mean years ± SD) 62.9 ±5.4 63.1 ±6.1 0.741
Male (%) 55.1 55.3 0.973
Latest grade of employment (%) b0.001
Higher 46.2 28.4
Intermediate 36.3 44.2
Lower 17.5 27.4
Current smoker (%) 4.5 6.3 0.374
Alcohol consumption (%) 0.633
No alcohol 13.0 19.2
Below recommended levels 75.0 64.9
Above recommended levels 12.0 15.9
Hours of physical activity per week (%) 0.073
b1 h 21.7 25.3
1–4 h 30.4 35.2
5–7 h 23.8 21.3
N7 h 24.1 18.3
Body mass index (mean Kg/m2 ± SD) 25.6 ±3.8 26.1 ±3.9 0.179
Systolic blood pressure (mean mm Hg ±
SD)
128.3 ±
15.7
130.1 ±
15.8
0.221
Diastolic blood pressure (mean mm Hg ±
SD)
69.6 ±8.9 69.9 ±8.5 0.694
Glycated haemoglobin (mean % ± SD) 5.5 ±0.5 5.5 ±0.4 0.659
Triglycerides (median g/L ± IQR) 1.1 ±0.8 1.2 ±0.7 0.974
HDL (mean mmol/L ± SD) 1.7 ±0.5 1.6 ±0.4 0.047
LDL (mean mmol/L ± SD) 3.0 ±0.9 3.0 ±0.8 0.591
Total cholesterol (mean mmol/L ± SD) 5.3 ±0.9 5.3 ±0.9 0.692
Total cholesterol/HDL ratio (mean ± SD) 3.3 ±1.1 3.4 ±1.0 0.284
HS-CRP (median mg/L ± IQR) 1.0 ±1.3 1.0 ±1.6 0.149
Salivary cortisol (mean nmol/L ± SD) 6.5 ±4.1 6.6 ±4.8 0.681
HS-IL-6 (median pg/ml ± IQR) 1.1 ±0.8 1.2 ±0.9 0.537
Von Willebrand factor (mean % ± SD) 104.2 ±
39.6
105.8 ±
39.9
0.648
MCP-1 (median pg/mL ± IQR) 137.2 ±
60.9
138.4 ±
53.5
0.431
CES-D (median score ± IQR) 4.0 ±7.0 6.0 ±8.0 0.002
SF-36 mental health (median score ± IQR) 84.0 ±
16.0
80.0 ±
20.0
0.001
SF-36 mental component (median score ±
IQR)
85.1 ±
10.8
82.0 ±
16.6
b0.001
Positive affect (median score ± IQR) 25.0 ±8.0 22.0 ±8.0 b0.001
Negative affect (median score ± IQR) 2.0 ±4.0 4.0 ±5.0 0.001
Agatston coronary calcium score (%) 0.954
None 42.5 44.7
b100 32.9 31.7
b400 16.4 12.5
400+ 8.2 11.1
HS-CTnT detectable (%) 17.5 16.3 0.743
HS-CTnT concentration if detectable
(median ng/L ± IQR)
5.6 ±3.9 5.8 ±4.4 0.661
SD = standard deviation. IQR = interquartile range. P values were computed using the
likelihood ratio test. Ordered categorical variables such as employment grade, alcohol con-
sumption, physical activity, and coronary calcium score were treated as linear (test for
trend).
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elevation. Cut-off points were set at 300 mg/dL (median and mean
value) or at 400 mg/dL (established clinical upper limit for normal
values) (Schmaier, 2012).
Financial strainwas considered as a binary variable (0=absent; 1=
present) with a cut-off using the minimum score of eight (58.4% of the
sample scored eight). An interaction parameter was calculated by mul-
tiplying fibrinogen (Z-score) and financial strain (binary) together.
Agatston CAC score had a right-skewed distribution and it was trans-
formed into an ordered categorical variable with four categories (cut-
offs at 0, 100, and 400). HS-CTnT was cut into a binary variable (detect-
able vs undetectable) because only about 17% of the sample had positive
values.
We used multiple logistic regression models to examine the com-
bined association of plasma fibrinogen concentration and financial
strain with HS-CTnT. The interaction between fibrinogen and finan-
cial strain was firstly assessed by means of stratified analyses,
which have the disadvantage of reducing the analytic sample size
and the advantage of giving a visual impression of the interaction.
We then assessed the interaction in the full sample using the multi-
plicative parameter as a covariate. We adjusted for demographics
such as age, gender, and employment grade, and for health behav-
iours such as physical activity, smoking and alcohol intake because
they are related to CVD and may confound the association between
fibrinogen and HS-CTnT. We also took into account clinical variables
that are known to be linked with CVD such as Body Mass Index
(BMI), blood pressure, glycated haemoglobin (HbA1c), triglycerides,
Low-Density Lipoprotein cholesterol (LDL), and total/High-Density
Lipoprotein (HDL) cholesterol ratio. Moreover, we adjusted for cir-
culating markers of inflammation and endothelial dysfunction such
as High-Sensitivity C-Reactive Protein (HS-CRP), salivary cortisol,
High-Sensitivity Interleukin-6 (HS-IL-6), von Willebrand Factor
(vWF), and Monocyte Chemoattractant Protein-1 (MCP-1) to ac-
count for vascular inflammation and endothelial dysfunction. We
also adjusted for chronic psychosocial stressors including CES-D
score, SF-36 scores, positive affect, negative affect, to assess if finan-
cial strain was independent from them. Finally, we adjusted for
Agatston CAC score to examine whether the interaction between fi-
brinogen and financial strain was independent of underlying coro-
nary atherosclerosis.
Financial strain was considered a priori as the best candidate for the
role of effect modifier, for the reasons explained in the Introduction.
However, we carried out additional analyses to also test the other psy-
chosocial variables for interaction.
Missing values wereminimal (b1%), were only present in the covar-
iates, andwere imputed usingmultiple chained equations (Royston and
White, 2011). Complete case analysis gave very similar results (data
shown in the Appendix). We evaluated the extent of multicollinearity
among covariates by computing one-to-one correlation coefficients
and by examining variance inflation factors (VIF) (“Regression with
Stata Web Book: Chapter 2 - Regression Diagnostics,”, n.d.). We per-
formed several sensitivity analyses: CAC was log-transformed (zero
values were recoded to values equal to the half of the smallest value
in the dataset) as well as other right-skewed covariates; SF-36 mental
health and SF-36 mental component showed left-skewed distributions
and we recoded their values to their reciprocal before the log-transfor-
mation.We used both theWald test and the Likelihood Ratio test to as-
sess the interactions.
A total of 543 people participated in the study, but 42 (7.7%) had
missing information for HS-CTnT or fibrinogen due to insufficient
blood samples and were therefore excluded. One participant had miss-
ing information for financial strain. The final analytic sample comprised
500 disease-free participants aged 63 years on average (standard devi-
ation [SD] = 5.7) of whom 55.2% were men. The excluded participants
did not differ significantly from the main sample on any of the
covariates.3. Results
Financial strainwas present in 41.6% of our sample. The average con-
centration of fibrinogen in the peripheral blood plasma was 314 mg/dL
(SD= 60.7), and 17.0% showed positivity for HS-CTnT in the peripheral
blood plasma.
Table 1 describes the sample according to financial strain. The de-
scription of skewed variables is presented using medians and inter-
quartile ranges (IQR). Peoplewith financial strain tended to have higher
concentrations offibrinogen, to have lower grades of employment, to be
less physically active, to have lower HDL cholesterol, and to score poorly
in other psychosocial measures.
Table 2
Multiple logistic regression models for the association between plasma fibrinogen concentrations and plasma detectable HS-CTnT by strata of financial strain.
Subgroup N Binary exposure variable Type of multiple logistic regression model for HS-CTnT positivity
Adjusted for demographicsa Further adjusted for health
behaviours, cardiovascular risk
factors, and psychosocial
stressorsb
Full model (further adjusted for
inflammatory cytokines and
coronary calcification)c
OR (95% CI) P OR (95% CI) P OR (95% CI) P
Low financial strain 292 Fibrinogen (N300 vs ≤300 mg/dL) 0.84 (0.42 to 1.67) 0.622 0.87 (0.40 to 1.90) 0.735 0.91 (0.40 to 2.08) 0.820
High financial strain 208 Fibrinogen (N300 vs ≤300 mg/dL) 4.73 (1.67 to 13.40) 0.003 4.82 (1.43 to 16.22) 0.011 3.86 (1.02 to 14.53) 0.046
Low financial strain 292 Fibrinogen (N400 vs ≤400 mg/dL) 0.40 (0.08 to 2.00) 0.263 0.29 (0.05 to 1.67) 0.167 0.26 (0.04 to 1.91) 0.186
High financial strain 208 Fibrinogen (N400 vs ≤400 mg/dL) 3.90 (1.22 to 12.49) 0.022 4.43 (1.05 to 18.68) 0.043 2.69 (0.55 to 13.12) 0.221
a Adjusted for age, gender, and latest grade of employment.
b Further adjusted for CES-D, SF-36mental health, SF-36mental component, positive affect, negative affect, smoking, alcohol consumption, physical activity, systolic and diastolic blood
pressure, LDL, total cholesterol/HDL ratio, triglycerides, glycated haemoglobin, and BMI.
c Further adjusted for HS-CRP, salivary cortisol, HS-IL-6, vWF, MCP-1, and Agatston coronary calcification score.
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after stratification for financial strain. After adjusting for demographic
variables, fibrinogen concentration levels above the average were asso-
ciated with a 5-fold increase in the odds of HS-CTnT positivity only
among individuals with financial strain (N = 208, OR = 4.73,
95%CI = 1.67 to 13.40, P = 0.003). Fibrinogen was not associated
with HS-CTnT positivity in people without financial strain, despite the
larger size of that subsample (n = 292, OR = 0.84, 95%CI = 0.42 to
1.67, P = 0.622). Further multiple adjustments did not change the pat-
tern of results noticeably. The resultswere also similarwhenwe applied
an alternative cut-off point to mark elevated fibrinogen (400 mg/dL in-
stead of the average 300 mg/dL).
Table 3 shows unstratified analyses, in which the synergy between
financial strain and fibrinogen was tested using an interaction parame-
ter as a covariate in the full sample. There was very strong evidence of
an interaction after adjusting for age and gender (OR = 2.09,
95%CI= 1.25 to 3.52, P=0.005). The strength of association did not de-
crease after further multiple adjustments, although the extent of statis-
tical evidence decreased but remained significant (OR = 2.07, 95%CI =
1.19 to 3.60, P = 0.010).
Table 4 shows the full output from the fully-adjusted multiple logis-
tic regression model. Fibrinogen and financial strain did not show anyTable 3
Multiple logistic regression models for the association of plasma fibrinogen concentration, fina
Model for detectable HS-CTnT
1. No further adjustments
2. Further adjusted for age and gender
3. Further adjusted for latest grade of employment
4. Further adjusted for CES-D, SF-36 mental health, SF-36 mental component, positive affe
and negative affect
5. Further adjusted for smoking, alcohol consumption, and physical activity
6. Further adjusted for systolic and diastolic blood pressure, LDL, total cholesterol/HDL rat
triglycerides, glycated haemoglobin, and BMI
7. Further adjusted for HS-CRP, salivary cortisol, HS-IL-6, vWF, and MCP-1
8. Further adjusted for Agatston coronary calcification score with 4 categories
TheORpertaining tofibrinogen is for one standarddeviation increase from themean (Z score). F
and financial strain.association with HS-CTnT, but there was a clear interaction between
these variables (P = 0.010), therefore fibrinogen may be a risk factor
for HS-CTnT elevation onlywhenfinancial strain is present. No other co-
variates in the model showed any evidence of association with the out-
come apart from age (P b 0.001) and gender (P b 0.001).
None of other psychosocial variables (CES-D, SF-36 mental health,
SF-36 mental component, positive affect, and negative affect) showed
any evidence of interaction with fibrinogen when they replaced finan-
cial strain.
The exclusion of one or more of those covariates showing
multicollinearity (correlation coefficient N 0.35 or VIF b 3) in rotation
and/or in combination did not alter the results distinctively. All sensitiv-
ity analyses gave similar results to the main analyses.
4. Discussion
Our results indicate that a single test result of elevated fibrinogen
might be associated with higher risk of cardiac disease only when it is
accompanied with financial strain.
We are therefore proposing a new approach to cardiovascular risk
assessment: inflammation and psychosocial stress may interact with
each other in the promotion of heart disease. Our results may helpncial strain, and an interaction parameter with plasma detectable HS-CTnT (n = 500).
Mutually-adjusted exposure variables OR (95%CI) P
Fibrinogen 0.98 (0.70 to 1.36) 0.893
Financial strain 0.80 (0.48 to 1.34) 0.401
Interaction 1.63 (1.02 to 2.61) 0.043
Fibrinogen 0.85 (0.59 to 1.21) 0.363
Financial strain 0.77 (0.44 to 1.36) 0.373
Interaction 2.09 (1.25 to 3.52) 0.005
Fibrinogen 0.83 (0.58 to 1.19) 0.318
Financial strain 0.75 (0.42 to 1.32) 0.312
Interaction 2.07 (1.23 to 3.47) 0.006
ct, Fibrinogen 0.84 (0.58 to 1.21) 0.354
Financial strain 0.77 (0.43 to 1.40) 0.397
Interaction 2.07 (1.23 to 3.51) 0.007
Fibrinogen 0.84 (0.58 to 1.22) 0.366
Financial strain 0.77 (0.43 to 1.39) 0.390
Interaction 2.07 (1.27 to 3.52) 0.007
io, Fibrinogen 0.80 (0.55 to 1.16) 0.236
Financial strain 0.78 (0.43 to 1.44) 0.432
Interaction 2.07 (1.20 to 3.55) 0.009
Fibrinogen 0.72 (0.47 to 1.09) 0.117
Financial strain 0.80 (0.43 to 1.47) 0.475
Interaction 2.11 (1.22 to 3.67) 0.008
Fibrinogen 0.71 (0.47 to 1.07) 0.105
Financial strain 0.80 (0.43 to 1.48) 0.473
Interaction 2.07 (1.19 to 3.60) 0.010
inancial strain is a binary variable (1 vs 0). Interaction=multiplication betweenfibrinogen
Table 4
Full output from thefinal fully-adjustedmultiple logistic regressionmodel for the association of plasma fibrinogen concentrations, financial strain, and their interaction with plasma
detectable HS-CTnT (n = 500).
Exposure variables Mutually-adjusted OR for detectable HS-CTnT (95%CI) P
Fibrinogen 0.71 (0.47 to 1.07) 0.105
Financial strain 0.80 (0.43 to 1.48) 0.473
Interaction fibrinogen X financial strain 2.07 (1.19 to 3.60) 0.010
Age 1.19 (1.12 to 1.26) b0.001
Male 5.34 (2.51 to 11.36) b0.001
Latest grade of employment 1.16 (0.77 to 1.73) 0.478
CES-D 0.98 (0.91 to 1.07) 0.706
SF-36 mental health 1.01 (0.97 to 1.05) 0.769
SF-36 mental component 0.98 (0.94 to 1.02) 0.263
Positive affect 0.99 (0.94 to 1.04) 0.580
Negative affect 0.91 (0.82 to 1.02) 0.105
Alcohol consumption 0.90 (0.52 to 1.54) 0.693
Physical activity 0.93 (0.71 to 1.22) 0.613
Smoking 1.09 (0.24 to 5.00) 0.911
Systolic blood pressure 1.00 (0.97 to 1.02) 0.841
Diastolic blood pressure 1.00 (0.95 to 1.05) 0.944
LDL 1.13 (0.68 to 1.88) 0.624
Total cholesterol/HDL ratio 0.91 (0.53 to 1.55) 0.721
Glycated haemoglobin 1.41 (0.81 to 2.45) 0.221
BMI 1.05 (0.96 to 1.15) 0.288
Triglycerides 0.55 (0.28 to 1.06) 0.072
HS-IL-6 0.99 (0.66 to 1.48) 0.970
HS-CRP 1.06 (0.92 to 1.23) 0.416
Cortisol 1.03 (0.96 to 1.09) 0.416
vWF 1.00 (1.00 to 1.01) 0.203
MCP-1 1.00 (0.99 to 1.00) 0.602
Agatston coronary calcification score 1.28 (0.96 to 1.71) 0.091
TheORpertaining tofibrinogen is for one standarddeviation increase from themean (Z score). Financial strain is a binary variable (1 vs 0). Interaction=multiplication betweenfibrinogen
and financial strain. The ORs pertaining to the other variables are for one unit increase, except for ordered categorical variables employment grade, alcohol consumption, physical activity,
and coronary calcification score, for which the ORs are for one category increase.
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the prediction of cardiac events in spite of inflammation being the
necessary precursor of heart disease: since the concentration of in-
flammatory biomarkers in the peripheral blood plasma changes
very rapidly in response to changes in environmental factors such
as acute stress, the presence or absence of chronic stress modifies
the weight that we should give to normal or abnormal test results
for inflammation. Our results suggest that in some instances such
weight may even be overturned, i.e. that abnormal test results may
be associated with favourable outcomes. Therefore an accurate risk
assessment based on single tests for inflammatory biomarkers be-
comes possible only after taking environmental factors into account
in an appropriate way.
We have used one established marker for psychosocial stress and
one for systemic inflammation, but both stress and inflammation are
umbrella terms for a range of indicators and interconnected markers
within each domain, and each indicatormeasures different but often re-
lated aspects of each phenomenon, thus future research must focus on
the identification and on the isolation of the most important
markers, i.e. those that show the highest degree of interaction. We
found an interaction between stress and inflammation only when
we used financial strain as a marker of stress. However, we cannot
be sure that financial strain is intrinsically more valuable or more
able to capture certain important psychosocial aspects compared to
the other available markers; financial strain has the advantage of
being an objective measure and therefore it may just be a more accu-
rate and more efficient marker compared to the others from a statis-
tical perspective. Interaction tests are in fact known to have low
power and therefore require large samples and very accurate mea-
sures. Hence, we cannot rule out the hypothesis that if these analyses
were replicated on a larger sample, the other stress markers would
similarly show interaction with inflammation. Future research may
also examine other markers of inflammation.
Our outcome was HS-CTnT, which is a recognised indicator of myo-
cardial damage and the most proximal sentinel marker for cardiacdisease, but it is necessary to challenge our results using a recorded clin-
ical event as an outcome.
Regarding sample size, interaction tests are known to require large
sample sizes to have sufficient statistical power and this fact further
strengthens our results achievedwith a relatively small sample. Howev-
er, the precision of the estimates might be improved if these analyses
were applied on a larger sample, as some of our estimates showed
large confidence intervals.
No other covariates in our full model showed good evidence of asso-
ciationwith the outcome (apart from age and gender, which are known
determinants of heart disease), and the variable measuring the stress-
inflammation interaction was by far the strongest in terms of effect
size and statistical significance. Therefore the effect of stress-inflamma-
tion interactionsmay be higher than those of established risk factors for
heart disease such as blood pressure and cholesterol, and moreover the
interaction appeared to be very robust and independent from other fac-
tors since its coefficient did not change after a number of multiple step-
wise adjustments (Table 3).
The prevalence of detectable HS-CTnT in our sample (17.0%) was
similar to that reported in a nationally-representative CVD-free popula-
tion sample in USA (15.7%) (de Lemos et al., 2010), and our normal
range (mean ± 1.96*SD) for plasma fibrinogen was 195 to 433 mg/dL,
which almost perfectly overlaps with the reference range for normal
values used in clinical practice (200 to 400 mg/dL) (Schmaier, 2012).
These findings suggest that the selection of participants was unbiased.
Our study involved participants free from cardiovascular disease be-
cause we are interested in the primary prevention of heart disease. This
approach has the disadvantage of generating results that are not neces-
sarily applicable to the general population or to high-risk groups. There-
fore analyses on wider and more representative population groups are
necessary to generalise our results.
This is a cross-sectional study and therefore we cannot determine
the causal sequence. Stress-inflammation interactions may contribute
to early signs of heart disease, or people at an early stage of cardiac dis-
ease may be more prone to disturbed stress-inflammation interactions.
51A.I. Lazzarino et al. / Preventive Medicine 93 (2016) 46–52If these findings were confirmed in larger, prospective studies against
robust cardiovascular events, they might open new approaches to car-
diovascular risk assessment in medical research. The results from a sin-
gle blood measure are not ideal and a continuous monitoring of these
parameters in conjunction with environmental factors seem more ap-
propriate, something that might become possible with the advent of
new technological devices able to capture real-time data (either self-re-
ported or physiological) in synchrony with biological markers.
The results from our research suggest that a finding of elevated plas-
ma fibrinogen may be the result of a healthy acute response to stress
and therefore it cannot always be interpreted as a marker of poorer
health. Moreover, there may be other reasons for a finding of elevated
inflammation, which alsomay be ormay be not associatedwith chronic
inflammation and disease, including genetic, metabolic, and personality
traits. Future research should take those possibilities into consideration.
No participants in our study reported acutemental stress reaction to
the needle insertion and the blood draw. We think that this due to the
fact that all our participants were volunteers and were informed about
the procedure prior to the testing sessions. Therefore it is highly likely
that none of them was prone to overreacting to the acute stress caused
by a needle insertion and a blood draw. To the contrary, during real-life
clinical assessments some people may overreact to that kind of acute
stress andmay release inflammatory factors as well as cardiac troponin
in response to the perceived stress. This phenomenon can lead towrong
diagnosis.
In conclusion, elevated fibrinogen seems to be cardio-toxic onlywhen
is combined with financial strain. The presence of chronic psychosocial
stress may modify the weight that we should give to single test results
for inflammation. Further research is needed to confirm our results.
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